New User? Sign Up | Sign In

Insider Trading - Akero Therapeutics Inc. (AKRO)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
AKRO Insider Trading Transactions for Akero Therapeutics Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-01-02
Sale
2020-01-06
8:59 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
72,444 $19.7 $1,427,272 3,256,124
(Indirect)
View
2020-01-06
Sale
2020-01-08
4:10 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
73,221 $19.86 $1,454,530 3,831,815
(Indirect)
View
2020-01-07
Sale
2020-01-09
8:11 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
53,057 $19.99 $1,060,845 3,203,067
(Indirect)
View
2020-01-08
Sale
2020-01-10
4:06 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
15,677 $19.86 $311,355 3,816,138
(Indirect)
View
2020-01-13
Sale
2020-01-14
08:58 am
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
494,000 $20.23 $9,993,620 3,322,138
(Indirect)
View
2020-01-10
Sale
2020-01-15
9:53 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
50,837 $20.04 $1,018,571 3,152,230
(Indirect)
View
2020-01-16
Sale
2020-01-21
9:57 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
59,532 $20.87 $1,242,403 3,092,698
(Indirect)
View
2020-02-04
Sale
2020-02-06
4:06 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
82,339 $25.77 $2,121,726 3,239,799
(Indirect)
View
2020-02-06
Sale
2020-02-10
5:47 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
6,102 $27.03 $164,955 3,233,697
(Indirect)
View
2020-02-11
Sale
2020-02-12
5:56 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
10,026 $27.07 $271,399 3,233,671
(Indirect)
View
2020-02-25
Sale
2020-02-27
7:51 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
5,904 $22.8 $134,635 3,227,767
(Indirect)
View
2020-02-28
Sale
2020-03-03
5:52 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
21,798 $22.63 $493,310 3,195,969
(Indirect)
View
2020-03-04
Sale
2020-03-06
5:23 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
45,950 $23.76 $1,091,608 3,150,019
(Indirect)
View
2020-07-01
Sale
2020-07-06
7:00 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
116,467 $34.4 $4,006,537 3,033,552
(Indirect)
View
2020-01-02
Sale(A)
2020-07-10
8:28 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
72,444 $19.7 $1,427,272 2,899,998
(Indirect)
View
2020-01-07
Sale(A)
2020-07-10
8:28 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
53,057 $19.99 $1,060,845 2,846,941
(Indirect)
View
2020-07-10
Purchase
2020-07-14
4:45 pm
Akero Therapeutics Inc. AKRO Harrison Seth Loring
Director
10% Owner
415,000 $36 $14,940,000 5,830,203
(Indirect)
View
2020-07-10
Purchase
2020-07-14
4:46 pm
Akero Therapeutics Inc. AKRO Apple Tree Partners IV L.P.
ATP III GP Ltd.
10% Owner
415,000 $36 $14,940,000 5,830,203
(Direct)
View
2020-10-09
Sale
2020-10-14
4:54 pm
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
13,000 $28.93 $376,090 11,780
(Indirect)
View
2021-01-04
Sale
2021-01-06
6:48 pm
Akero Therapeutics Inc. AKRO Young Jonathan
COO
3,060 $25.29 $77,399 181,785
(Indirect
Direct)
View
2021-01-07
Sale
2021-01-11
7:54 pm
Akero Therapeutics Inc. AKRO Young Jonathan
COO
10,000 $28.12 $281,200 179,285
(Indirect
Direct)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
684,143 $0 3,256,124
(Indirect)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
13,683 $0 3,256,124
(Indirect)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
13,683 $0 3,256,124
(Indirect)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
11,803 $0 3,256,124
(Indirect)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
11,803 $0 3,256,124
(Indirect)
View
2020-01-10
Exercise
2020-01-10
7:39 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
17,621 $0.615 100,350
(Direct)
View
2020-01-10
Exercise
2020-01-10
7:39 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
21,286 $0.615 100,350
(Direct)
View
2020-01-10
Exercise
2020-01-10
7:39 pm
N/A
2028-07-29
Akero Therapeutics Inc. AKRO Young Jonathan
COO
17,621 $0.615 100,350
(Direct)
View
2020-01-10
Exercise
2020-01-10
7:39 pm
N/A
2028-10-17
Akero Therapeutics Inc. AKRO Young Jonathan
COO
21,286 $0.615 100,350
(Direct)
View
2020-02-07
Other
2020-02-10
7:49 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Atlas Venture Opportunity Fund I L.P.
10% Owner
50,510 $0 404,079
(Indirect)
View
2020-03-12
Exercise
2020-03-13
7:04 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
27,368 $0.61 42,796
(Direct)
View
2020-03-12
Exercise
2020-03-13
7:04 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
22,656 $0.61 42,796
(Direct)
View
2020-03-12
Exercise
2020-03-13
7:04 pm
N/A
2028-10-17
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
27,368 $0.61 42,796
(Direct)
View
2020-03-12
Exercise
2020-03-13
7:04 pm
N/A
2028-07-29
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
22,656 $0.61 42,796
(Direct)
View
2020-03-13
Exercise
2020-03-16
5:51 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
5,035 $0.615 94,268
(Direct)
View
2020-03-13
Exercise
2020-03-16
5:51 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
6,082 $0.615 94,268
(Direct)
View
2020-03-13
Exercise
2020-03-16
5:51 pm
N/A
2028-07-29
Akero Therapeutics Inc. AKRO Young Jonathan
COO
5,035 $0.615 94,268
(Direct)
View
2020-03-13
Exercise
2020-03-16
5:51 pm
N/A
2028-10-17
Akero Therapeutics Inc. AKRO Young Jonathan
COO
6,082 $0.615 94,268
(Direct)
View
2020-03-30
Exercise
2020-04-01
6:52 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Graham G. Walmsley
Director
2,168 $19.97 23,832
(Direct)
View
2020-03-30
Exercise
2020-04-01
6:52 pm
N/A
2029-11-07
Akero Therapeutics Inc. AKRO Graham G. Walmsley
Director
2,168 $19.97 23,832
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:52 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Harrison Seth Loring
Director
10% Owner
13,000 $25.2 13,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:53 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Graham G. Walmsley
Director
13,000 $25.2 13,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:54 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
13,000 $25.2 13,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:54 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Iwicki Mark T
Director
13,000 $25.2 13,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:54 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Henderson Jane
Director
13,000 $25.2 13,000
(Direct)
View
2020-06-09
Option Award
2020-06-11
7:01 pm
N/A
2030-06-09
Akero Therapeutics Inc. AKRO Heyman Tomas J.
Director
26,000 $25.04 26,000
(Direct)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
684,143 $0 2,899,998
(Indirect)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
13,683 $0 2,899,998
(Indirect)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
13,683 $0 2,899,998
(Indirect)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
11,803 $0 2,899,998
(Indirect)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
11,803 $0 2,899,998
(Indirect)
View
2020-12-08
Option Award
2020-12-09
8:47 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
1,245 $17.07 242,500
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:47 pm
N/A
2030-12-07
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
242,500 $28.35 242,500
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:49 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
1,245 $17.07 77,580
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:49 pm
N/A
2030-12-07
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
77,580 $28.35 77,580
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:50 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Yale Catriona
Chief Development Officer
1,245 $17.07 77,580
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:50 pm
N/A
2030-12-07
Akero Therapeutics Inc. AKRO Yale Catriona
Chief Development Officer
77,580 $28.35 77,580
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:52 pm
N/A
N/A
Akero Therapeutics Inc. AKRO White William Richard
CFO
1,245 $17.07 77,580
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:52 pm
N/A
2030-12-07
Akero Therapeutics Inc. AKRO White William Richard
CFO
77,580 $28.35 77,580
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:53 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
1,245 $17.07 77,580
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:53 pm
N/A
2030-12-07
Akero Therapeutics Inc. AKRO Young Jonathan
COO
77,580 $28.35 77,580
(Direct)
View
2020-12-21
Gift
2020-12-23
4:19 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
50 $0 286,192
(Direct)
View
2020-12-21
Gift
2020-12-23
4:19 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
2,500 $0 286,192
(Direct)
View
2020-12-21
Exercise
2020-12-23
4:19 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
10,500 $0.62 286,192
(Direct)
View
2020-12-21
Exercise
2020-12-23
4:19 pm
N/A
2028-09-07
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
10,500 $0.62 286,192
(Direct)
View
2020-12-28
Exercise
2020-12-29
4:53 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
7,480 $0.62 278,712
(Direct)
View
2020-12-28
Exercise
2020-12-29
4:53 pm
N/A
2028-09-07
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
7,480 $0.62 278,712
(Direct)
View
2021-01-07
Exercise
2021-01-11
7:54 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
7,500 $0.615 179,285
(Direct)
View
2021-01-07
Exercise
2021-01-11
7:54 pm
N/A
2028-07-29
Akero Therapeutics Inc. AKRO Young Jonathan
COO
7,500 $0.615 179,285
(Direct)
View
2021-01-07
Exercise
2021-01-11
7:57 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
20,000 $0.615 258,712
(Direct)
View
2021-01-07
Gift
2021-01-11
7:57 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
3,000 $0 258,712
(Direct)
View
2021-01-07
Exercise
2021-01-11
7:57 pm
N/A
2028-09-07
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
20,000 $0.615 258,712
(Direct)
View
Goto page 0, 1, Next